MedDay Pharmaceuticals SA
10 clinical trials · Sponsor
◉ Watch MedDay Pharmaceuticals SA
| Record | Firm | Date |
|---|---|---|
| Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-MD1003 in Healthy Male Subjects (NCT04223232) | MedDay Pharmaceuticals SA | 2019-12-10 |
| TQT2 Study to Evaluate the Effect of MD1003 on Cardiac Repolarization in Healthy Adult Subjects (NCT04168723) | MedDay Pharmaceuticals SA | 2019-11-11 |
| HI Study to Assess and Compare the Pharmacokinetic Parameters of MD1003 in Hepatic Impaired Patients and Healthy Subjects (NCT04252417) | MedDay Pharmaceuticals SA | 2019-10-11 |
| RI Study to Assess and Compare the Pharmacokinetic Parameters of MD1003 in Renal Impaired Patients and Healthy Subjects (NCT04252430) | MedDay Pharmaceuticals SA | 2019-10-09 |
Track MedDay Pharmaceuticals SA automatically
Every clearance here is in the API, with alerts when new ones post.